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Radiological features Clinical information 
A 31-year-old man with chronic renal 
failure from membranoprol i ferat ive 
glomerulonephritis who had been on 
hemodialysis for 9 years presented 
with numerous, hard, painful spots on 
the skin of  his hands, feet, and ear- 
lobes. He also complained of episodic 
joint pains and symptoms of biventric- 
ular heart  failure. He had two failed 
kidney transplants, and a successful 
parathyroidectomy 8 years previous- 
ly. The serum calcium at the time of  
presentation was low at 8 .0mg/dL 
(normal, 8 .8-10.4mg/dL)  and the al- 
kaline phosphatase and phosphate 
levels were both elevated being 524 
IU/L  (normal, 30 -130IU/L)  and 
6.1mg/dL (normal, 2 .5-4 .9mg/dL)  
respectively. The serum creatinine was 
14.0mg/dL and the urea 92mg/dL.  
Films of  the hands (Fig. 2) and 
ankle (Fig. 3) demonstrated soft tis- 
sue calcification. 
Fig. 1. Photograph of the right hand showing multiple 
punctate white calcific deposits in the skin on the 
flexor surfaces of the phalanges 
Fig. 2. A Anteroposterior radiograph of the hands and 
B magnified view of left thumb show diffuse, punctate 
calcification of the soft tissues, predominantly on the 
flexor surfaces, and calcification of flexor tendon 
sheaths 
Fig. 3. Lateral view of the right ankle shows 
calcification in the heel pad 
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Diagnosis: Secondary oxalosis 
complicating chronic renal failure 
(oxalate gout [9]) 
The serum oxalate level in this patient 
was 8.8 mg/L (level in normal volun- 
teer, < 0.4mg/L). 
Histological studies of the skin 
(Fig. 4) showed rhomboidal, strongly 
birefringent crystals in the upper re- 
ticular dermis, without an accom- 
panying inflammatory reaction, 
fully consistent with calcium oxalate 
deposition. 
Many other causes of soft tissue 
calcification in the hands and feet, 
including gout, hyperparathyroidism, 
sarcoidosis, and calcinosis universalis 
do not cause diffuse punctate calcifi- 
cation as is seen in this case, but tend 
to cause dense masses of calcification 
around the joints. In myositis os- 
sificans, muscles around the larger 
joints, particularly the hip, are invol- 
ved by sheets of ossification, so this is 
not a diagnostic possibility here. 
Calcium pyrophosphates accu- 
mulate in articular tissues, but are 
not found diffusely in the skin as in 
this case. While they are rhomboidal 
in shape, they are not so strongly 
birefringent as calcium oxalate. Fur- 
thermore, in the present case, the 
crystals failed to stain with alizarin 
red S, as crystals of calcium pyro- 
phosphate do [1]. 
Urate deposits are typically bire- 
fringent, but the crystals are needle- 
shaped and are usually associated 
with a conspicuous giant-celled tissue 
reaction. Also, the present skin bio- 
psy material was fixed in formalin and 
processed routinely in aqueous and 
alcoholic solutions in which urate, 
but not calcium oxalate, readily dis- 
solves [1]. 
Discussion 
A striking similarity exists between 
this case and one of the four cases 
with oxalosis secondary to end-stage 
renal failure shown and described by 
Reginato et al. [6]. In the patient he 
described, there was miliary depo- 
sition of calcium oxalate crystals in 
the flexor tendon sheaths of the fin- 
gers and in skin predominantly in 
the hands and also around joints. 
Clinical manifestations in their four 
patients, who had been on long-term 
hemodialysis, included podagra, ten- 
osynovitis, olecranon bursitis, and 
acute or chronic synovitis of both 
large and small joints. Skin deposits 
were visible in the fingers and ears, as 
in the case here reported, and in the 
nose. 
Acquired oxalosis is a rare dis- 
order usually observed in association 
with renal failure. It should not be 
confused with primary oxalosis which 
A. Coral et al.: Case report 599 
is a hereditary metabolic defect result- 
ing in hyperoxalemia, renal depo- 
sition of oxalate, and progressive 
renal failure. Oxalate is a nonmeta- 
bolizable end product of glycine and 
ascorbic acid metabolism and virtu- 
ally all of it is normally excreted 
by the kidneys. Deposition of oxa- 
late in the kidney, thyroid, and my- 
ocardium, and less commonly in the 
lungs and spleen, can be shown by 
histological studies at post mortem in 
patients with renal failure [2]. Depo- 
sition in bone has also been reported 
[4]. Hoffman has shown that chon- 
drocalcinosis occurring in renal fai- 
lure is sometimes caused by oxalate 
deposition and that oxalate depo- 
sition in joints can cause synovitis 
[3]. Deposition of oxalate occurs 
when the production of oxalate from 
endogenous or exogenous processes 
exceeds the solubility product of cal- 
cium oxalate. 
Generally, oxalosis may occur as 
a result of increased intake, usually 
from ingesting large quantities of 
rhubarb; increased production fol- 
lowing ingestion or use of glycols, 
xylitol, or methoxyflurane; increased 
uptake from the gut in patients with 
extensive inflammatory bowel dis- 
ease; and from problems with ex- 
cretion in renal failure [1]. Oxalosis 
complicating renal failure is due in 
part to renal retention of oxalate. The 
Pathological features 
Fig. 4. Photomicrograph of a histologic 
section of skin from a finger (HE, • 200, 
polarized light microscope) shows dermal, 
rhomboidal, birefringent crystals 
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plasma oxalate levels are often high in 
renal failure and reflect the plasma 
urea level, so that levels of both are 
high immediately before, and low 
immediately after, a period of dialysis 
[9]. Oxalate deposition tends to be 
more severe in patients who have been 
in renal failure for longer periods [2]. 
Previous reports of secondary 
oxalosis producing symptoms are 
similar to this one in that the patients, 
with a single exception [7], were in- 
gesting large doses of vitamin C [3, 6]. 
The elevation of  serum vitamin C 
levels in patients taking supplemental 
vitamin C tablets on dialysis has been 
shown to correlate with serum oxalate 
and is one of  the metabolic precursors 
of oxalate, although the exact path- 
way is not fully known [5]. 
In the patient shown here, it is 
interesting that the skin calcification 
occurred in areas such as the heel pad 
and the flexor surfaces of  the fingers 
which are frequently subjected to 
pressure. 
The diagnosis was first made by a 
radiologist who noted the similarity 
of the diffuse synovial and skin calci- 
fication to that reported by Reginato 
et al. [6]. We believe the radiologists 
should be aware of this rare compli- 
cation of long-term hemodialysis as 
the diagnosis may be more obvious 
radiologically than clinically. The 
condition can then be treated by ceas- 
ing oral intake of vitamin C and re- 
moving it from the dialysate in or- 
der to reduce endogenous oxalate 
production. 
The term oxalate gout has been 
suggested for the occurrence of  joint 
involvement and symptoms in sec- 
ondary oxalosis [8], acknowledging 
its first use by Loeper in 1932. 
The histological characteristics of 
oxalate have been thoroughly re- 
viewed by Chaplin [1]. Distinguishing 
oxalate from other calcium salts 
depends on its optical properties 
(birefringence), its solubility (it is in- 
soluble in water, alkalis, alcohol, and 
other organic solvents), and its stain- 
ing characteristics. Microincineration 
techniques have also been shown to 
be valuable. 
In summary a case is presented of  a 
31-year-old man with renal failure 
who developed miliary calcification in 
the skin and the synovium. Clinically, 
radiologically, and histologically the 
findings were typical of secondary 
oxalosis. It was emphasized in this 
article that acquired oxalosis is rare in 
association with renal failure. Ac- 
quired oxalosis must not be confused 
with primary oxalosis - a hereditary 
metabolic defect. It was stressed that 
chondrocalcinosis occurring in renal 
failure may be caused by deposition 
of oxalates which can produce syn- 
ovitis. The causes of oxalosis have 
been reviewed and it is stressed that 
oxalosis complicating renal failure 
may occur in part due to renal reten- 
tion of oxalate. The literature was 
reviewed concerning secondary oxa- 
losis, and the relationship of oxa- 
losis to the level of serum vitamin C 
in dialysis patients ingesting sup- 
plemental vitamin C tablets has been 
described. Secondary oxalosis, as in 
this patient, can be treated by remov- 
ing vitamin C from the dialysate. The 
histological characteristics of  oxalosis 
have been considered. 
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